The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss
The Journal of Physiology · 2024
DOI: 10.1113/jp285599 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2024. Verfasst von Satoe Takahashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Deafness, Hearing Loss. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCD NIH HHS.
Abstract (Originalsprache)
DFNB61 is a recessively inherited nonsyndromic hearing loss caused by mutations in SLC26A5 , the gene that encodes the voltage‐driven motor protein, prestin. Prestin is abundantly expressed in the auditory outer hair cells that mediate cochlear amplification. Two DFNB61‐associated SLC26A5 variants, p.W70X and p.R130S, were identified in patients who are compound heterozygous for these nonsense and missense changes ( SLC26A5 W70X/R130S ). Our recent study showed that mice homozygous for p.R130S ( Slc26a5 R130S/R130S ) suffer from hearing loss that is ascribed to significantly reduced motor kinetics of prestin. Given that W70X‐prestin is nonfunctional, compound heterozygous Slc26a5 R130S/− mice were used as a model for human SLC26A5 W70X/R130S . By examining the pathophysiological consequences of p.R130S prestin when it is the sole allele for prestin protein production, we determined that this missense change results in progressive outer hair cell loss in addition to its effects on prestin's motor action. Thus, this study defines the pathogenic roles of p.R130S prestin and identifies a limited time window for potential clinical intervention. image Key points The voltage‐driven motor protein, prestin, is encoded by SLC26A5 and expressed abundantly in cochlear outer hair cells (OHCs). The importance of prestin for normal hearing was demonstrated in mice lacking prestin; however, none of the specific SLC26A5 variants identified to date in human patients has been experimentally demonstrated to be pathogenic. In this study we used both cell lines and a mouse model to define the pathogenic role of compound heterozygous p.W70X (c.209G>A) and p.R130S (c.390A>C) SLC26A5 variants identified in patients with moderate to profound hearing loss. As in patients, mice carrying one copy of p.R130S Slc26a5 s howed OHC dysfunction and progressive degeneration, which results in congenital progressive hearing loss. This is the first functional study reporting pathogenic SLC26A5 variants and pointing to the presence of a therapeutic time window for potential clinical interventions targeting the affected OHCs before they are lost.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Communication Sciences and Disorders, Northwestern University, Evanston, Illinois, USA.
- The Hugh Knowles Center for Clinical and Basic Science in Hearing and Its Disorders, Northwestern University, Evanston, Illinois, USA.
ORCID-Profile: Kazuaki Homma
Förderung
- NCI NIH HHS
- NIDCD NIH HHS
Zitieren
APA
Takahashi, S., Zhou, Y., Cheatham, M. A., & Homma, K. (2024). The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss. The Journal of Physiology. https://doi.org/10.1113/jp285599
Vancouver
Takahashi S, Zhou Y, Cheatham MA, Homma K. The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss. The Journal of Physiology. 2024. doi:10.1113/jp285599
BibTeX
@article{Takahashi2024,
author = {Takahashi, Satoe and Zhou, Yingjie and Cheatham, Mary Ann and Homma, Kazuaki},
title = {The pathogenic roles of the p.R130S prestin variant in DFNB61 hearing loss},
journal = {The Journal of Physiology},
year = {2024},
doi = {10.1113/jp285599}
}
EUVIMED